Abstract
Background: Therapies with combined drugs have indicated better efficiency in the treatment of urothelial carcinomas. The anthelmintic drug Nitazoxanide (NTZ) has shown promising results of anti-tumor and immunomodulatory action, which makes it a suitable candidate for combined therapies with the Bacillus Calmette-Guérin. Aims: To characterize and compare c-Myc activation between therapie…